Comparative efficacy of AAC and ibuprofen versus lasmiditan, ubrogepant, and rimegepant for the acute treatment of episodic migraine in adults: a systematic review and network meta-analysis

Ashoke Mitra, Billy Franks, Richard Petruschke, Abhijeet Dhiman, Nitu Bansal · 2026

Read Comparative efficacy of AAC and ibuprofen versus lasmiditan, ubrogepant, and rimegepant for the acute treatment of episodic migraine in adults: a systematic review and network meta-analysis by Ashoke Mitra, Billy Franks, Richard Petruschke, Abhijeet Dhiman, Nitu Bansal (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13619513.txt.

Description

Ashoke Mitra and co-authors compare migraine treatments in a 2026 systematic review and network analysis of trials. Many drug options exist for acute migraine, but common over-the-counter choices are rarely tested directly against newer prescription drugs. The therapy under study pairs an antihistamine and caffeine combination with ibuprofen.

Because head-to-head trials are scarce, the team combined randomized trials into a network that allows indirect comparison across treatments. Rivals included lasmiditan and the newer CGRP-blocking drugs ubrogepant and rimegepant. The results help adults with episodic migraine and their doctors judge whether a cheap shelf option can match newer prescription drugs.

Catalog record

CREATORAshoke Mitra, Billy Franks, Richard Petruschke, Abhijeet Dhiman, Nitu Bansal
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13619513

Browse the full library · About the Tower of Babel